Sertraline and Blood Pressure
Sertraline does not typically increase blood pressure in most patients and may actually lower it in certain contexts, particularly in hemodialysis patients. However, as with all SSRIs, it can rarely cause hypertension as part of serotonin syndrome when combined with other serotonergic medications 1.
Blood Pressure Effects
The evidence regarding sertraline's cardiovascular effects is reassuring:
General population: Sertraline is classified among SSRIs as having minimal effects on blood pressure 2. A 2025 meta-analysis found sertraline significantly reduced systolic blood pressure by approximately 3.82 mmHg (95% CI: -7.48 to -0.16 mmHg) 3.
Hemodialysis patients: Sertraline has been specifically studied for its ability to increase blood pressure during dialysis sessions. Multiple studies demonstrate it raises mean arterial pressure by approximately 8.5 mmHg and reduces hypotensive episodes by 35-43% 4, 5, 6. This paradoxical benefit occurs through modulation of the Bezold-Jarisch reflex.
Cardiovascular safety: In a post-marketing trial of 372 patients with recent myocardial infarction or unstable angina, sertraline (50-200 mg/day) showed no significant cardiovascular events compared to placebo 7.
Important caveat: The one scenario where sertraline can cause dangerous hypertension is as part of serotonin syndrome when combined with other serotonergic drugs (MAOIs, other SSRIs/SNRIs, tramadol, certain stimulants). This presents with hypertension, tachycardia, mental status changes, neuromuscular hyperactivity, and autonomic instability 1.
Early Morning Awakening
Sertraline can cause insomnia and sleep disturbances, including early morning awakening, though this is not its most common sleep-related side effect. The evidence shows:
General SSRI effects: SSRIs as a class commonly cause "insomnia or somnolence" as typical side effects 2. The 2020 AACAP guidelines specifically note that SSRIs can cause insomnia 1.
Discontinuation syndrome: Sertraline is specifically associated with discontinuation syndrome (along with paroxetine and fluvoxamine), which includes insomnia among its symptoms 1. This can occur with missed doses or abrupt cessation 7.
Timing considerations: The FDA label notes insomnia as a recognized adverse effect but does not specify early morning awakening as distinct from general insomnia 7.
Clinical context: One study noted citalopram patients experienced "nausea and sleep disturbances" 2, suggesting sleep disruption is a recognized SSRI effect, though the specific pattern varies by individual.
Practical Management
If early morning awakening occurs with sertraline:
- Dosing time: Consider switching from evening to morning dosing, as sertraline can be dosed either morning or evening 2, 8
- Dose relationship: Sleep disturbances may be dose-related and could improve with dose reduction if clinically appropriate
- Duration: Initial sleep disturbances often improve after the first few weeks of treatment
- Behavioral activation: Early in treatment, SSRIs can cause behavioral activation/agitation (more common in younger patients), which includes insomnia 1. This typically occurs in the first month and may improve with dose reduction
Monitor closely: The FDA recommends close monitoring especially during initial treatment and dose changes for adverse events including sleep disturbances 8, 7.